Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in IMRX — Immuneering Corp

CIK 1446194 BALA CYNWYD, PA

Position in IMRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$344,574
-$211,447 QoQ
Shares Held
69,053
-34.6% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 111 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMRX Over Time

Shares Held

Position Value (USD)

Derivatives in IMRX

reported options exposure · as of Jun 30, 2026
CallValue
$1,409,675
CallShares
282,500
PutValue
$544,409
PutShares
109,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. IMRX ranks #185 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IMRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $344,574 69,053
2026-06-30 $544,409 109,100
2026-06-30 $1,409,675 282,500
2026-03-31 $427,397 81,100
2026-03-31 $556,021 105,507
2026-03-31 $734,111 139,300
2025-12-31 $431,648 65,600
2025-12-31 $707,165 107,472
2025-12-31 $329,658 50,100
2024-06-30 $113,607 88,756
2023-12-31 $77,932 10,603
2023-03-31 $562,684 57,949
2022-12-31 $218,250 45,000